These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24567278)

  • 21. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting.
    Blanco Tarrio E; Gálvez Mateos R; Zamorano Bayarri E; López Gómez V; Pérez Páramo M
    Clin Drug Investig; 2013 Sep; 33(9):633-45. PubMed ID: 23912474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study.
    Park CK; Kang HW; Oh IJ; Kim YC; Kim YK; Na KJ; Ahn SJ; Kim TO; Choi YJ; Song GA; Lee MK
    J Korean Med Sci; 2016 Dec; 31(12):1914-1921. PubMed ID: 27822929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study.
    Gatti A; Sabato AF; Occhioni R; Colini Baldeschi G; Reale C
    Eur Neurol; 2009; 61(3):129-37. PubMed ID: 19092248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients.
    Garassino MC; Piva S; La Verde N; Spagnoletti I; Iorno V; Carbone C; Febbraro A; Bianchi A; Bramati A; Moretti A; Ganzinelli M; Marabese M; Gentili M; Torri V; Farina G
    PLoS One; 2013; 8(4):e59981. PubMed ID: 23577077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysis.
    Parsons B; Sanin L; Yang R; Emir B; Juhn M
    Curr Med Res Opin; 2013 Dec; 29(12):1675-83. PubMed ID: 23998397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial.
    van Seventer R; Feister HA; Young JP; Stoker M; Versavel M; Rigaudy L
    Curr Med Res Opin; 2006 Feb; 22(2):375-84. PubMed ID: 16466610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of OROS® hydromorphone in patients suffering from severe chronic pain: A Study undertaken in routine clinical practice.
    Stepanović A; Pirc J; Lahajnar Čavlović S
    Wien Klin Wochenschr; 2011 Sep; 123(17-18):531-5. PubMed ID: 21710117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.
    Simpson DM; Schifitto G; Clifford DB; Murphy TK; Durso-De Cruz E; Glue P; Whalen E; Emir B; Scott GN; Freeman R;
    Neurology; 2010 Feb; 74(5):413-20. PubMed ID: 20124207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination pharmacotherapy for the treatment of neuropathic pain in adults.
    Chaparro LE; Wiffen PJ; Moore RA; Gilron I
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD008943. PubMed ID: 22786518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.
    Coluzzi F; Mattia C
    Minerva Anestesiol; 2010 Dec; 76(12):1072-84. PubMed ID: 21102402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
    Farrar JT; Young JP; LaMoreaux L; Werth JL; Poole MR
    Pain; 2001 Nov; 94(2):149-158. PubMed ID: 11690728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury.
    Cardenas DD; Nieshoff EC; Suda K; Goto S; Sanin L; Kaneko T; Sporn J; Parsons B; Soulsby M; Yang R; Whalen E; Scavone JM; Suzuki MM; Knapp LE
    Neurology; 2013 Feb; 80(6):533-9. PubMed ID: 23345639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
    Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J
    Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.
    Lesser H; Sharma U; LaMoreaux L; Poole RM
    Neurology; 2004 Dec; 63(11):2104-10. PubMed ID: 15596757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study.
    Baron R; Martin-Mola E; Müller M; Dubois C; Falke D; Steigerwald I
    Pain Pract; 2015 Jun; 15(5):455-70. PubMed ID: 24738609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral osmotic hydromorphone (OROS) in patients with chronic severe pain due to osteoarthritis under daily routine conditions].
    Müller-Schwefe GH; Blimke B; Hesselbarth S; Giesecke T
    MMW Fortschr Med; 2014 Apr; 156 Suppl 1():23-9. PubMed ID: 24930329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study.
    Wallace M; Rauck RL; Moulin D; Thipphawong J; Khanna S; Tudor IC
    Int J Clin Pract; 2007 Oct; 61(10):1671-6. PubMed ID: 17877652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis.
    Lazzari M; Sabato AF; Caldarulo C; Casali M; Gafforio P; Marcassa C; Leonardis F
    Curr Med Res Opin; 2014 Apr; 30(4):555-64. PubMed ID: 24251879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.